PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
2.74
1 yrs 1 m
0%
553.17 Crs
NIL upto 10% of units and 1% for remaining units on or before 1Y, Nil after 1Y
Large Growth
9.37
SIP 500 & Lumpsum 1000
BSE HEALTH CARE - TRI
Sanjay Chawla,Ankeet Pandya
Investors understand that their principal will be at very high risk